genprowebdirectory
GEN Edge
News
Insights
Trends for 2021
Trends for 2020
A-Lists
Topics
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Magazine
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Search
Advertising
Magazine Advertising
Website Banner Advertising
eNewsletter Advertising
Webinar Sponsorship
eBook Advertising
Email Nurture Campaigns
Ad Terms and Conditions
About GEN
Contact GEN
Create a Free Account
Get GEN Edge
Log In
GEN – Genetic Engineering and Biotechnology News
Mary Ann Liebert, Inc. Publishers
GEN Edge
Gene Therapy
Bayer Approach to Partnerships, Pipelines, and Platforms
Genomics
Genomics in the Clinic: A Candid Conversation with Sema4 CEO Eric…
Circulating Tumor Cell
Illumina Launching Pan-Cancer IVD Test, Cloud-Based Bioinformatics Platform
Biomarkers
Guardant Health Launches Early-Stage Colorectal Cancer ctDNA Assay
GEN Edge
EY Firepower Report: Biopharma M&A Poised to Rebound in 2021
News
Coronavirus
Seasonal Coronaviruses’ Spike Proteins Evolve to Evade Immune Responses
Cancer
A New Role for Androgen Receptors in Breast Cancer Revealed
Therapeutics
Harmful and Healing Responses to Brain Injury Diverge by Cellular Mediators…
Drug Discovery
Novel Synthesis Method Aids Rapid Testing of Vaccine Strategies against Respiratory…
CRISPR-Cas9
Natural CRISPR’s Safety Feature Could Become Genetic Dimmer Switch
Insights
All
Trends for 2021
Trends for 2020
Bioprocessing
Biopharma Manufacturers Shouldn’t Rush When “Going Digital”
Bioprocessing
Separating Cells with Microfluidics
Trends for 2021
Beyond 2021: Cell Therapy Manufacturing Trends
Bioprocessing
Machine Learning for Better Bioprocess Data Analysis
A-Lists
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
A-Lists
Top 15 Best-Selling Drugs Launched in 2020
A-Lists
Top 50 NIH-Funded Institutions of 2020
July 2020 Vol. 40 No. 7
Top 10 Earners among Women Biopharma Executives
June 2020 Vol. 40 No. 6
In Praise of Lesser-Sung Life Sciences Clusters
Topics
All
Bioprocessing
Cancer
Drug Discovery
OMICs
Translational Medicine
Genome Editing
Cancer
A New Role for Androgen Receptors in Breast Cancer Revealed
eBooks
A Deep Dive into Perfusion Media for Bioprocessing Applications
Therapeutics
Harmful and Healing Responses to Brain Injury Diverge by Cellular Mediators…
Drug Discovery
Novel Synthesis Method Aids Rapid Testing of Vaccine Strategies against Respiratory…
Magazine
January 2021 Vol. 41 No. 1
Seven Biopharma Trends to Watch in 2021
January 2021 Vol. 41 No. 1
Leroy Hood: Reflections on a Legendary Career
January 2021 Vol. 41 No. 1
COVID-19 One Year Later: The Biology and the Business
Traditional Medicine
Monoclonal Antibodies: Developers Explore New Territories
Roundtable
Uncharted Territory: Top Challenges Facing Gene Therapy Development
Resources
All
GEN Live
Posters
Videos
Webinars
eBooks
Podcasts
Events
New Products
Tutorial
Best of the Web
Best Apps
Subscribe
Create a Free Account
Get GEN Edge
Log In
Get GEN Magazine
Get GEN eNewsletters
Get the GEN Mobile App
Get GEN News from Alexa
Home
Companies
Merck & Co
Merck & Co
Latest
Latest
Featured posts
Most popular
7 days popular
By review score
Random
Merck & Co
Merck & Co. to Acquire VelosBio for $2.75B, Expanding Cancer Pipeline
Merck & Co
Merck & Co. Commits Up to $4.2B toward Seattle Genetics Cancer Partnerships
Merck & Co
As Pressure Mounts, CEOs Commit to Science, Safety in Developing COVID-19 Vaccines
Merck & Co
COVID-19 Triple Play: Merck Acquiring Themis, Partnering with Ridgeback, IAVI
Merck & Co
Merck & Co. Partnering with ISB to Study Targets for COVID-19 Therapeutics
Merck & Co
Merck & Co. Launches Up-to-$2.5B Cancer Collaboration with Taiho, Astex
Merck & Co
Merck & Co., Sanofi Shell Out $5.2B in Deals to Strengthen...
Merck & Co
Merck Acquires TRPML1 Agonist Developer Calporta for Up to $576M
Merck & Co
Merck & Co. Eliminating 500 U.S. Sales, Commercial Jobs
Merck & Co
Merck & Co. Partners with Themis on Measles Virus Vector-Based Vaccines
Merck & Co
Merck & Co., Skyhawk Collaborate on RNA-Binding Small Molecule Therapies
Merck & Co
Merck & Co. Expands Pipeline in Cancer, Fibrosis, Autoimmune Diseases by...
Merck & Co
Merck & Co. to Acquire Peloton for Up to $2.2B, Adding...
Merck & Co
Citing “Strong Sales,” Pension Manager Buys Partial Keytruda Rights for $1.3B
Merck & Co
Merck & Co. Plans Jobs Cuts, Shutdowns in Up-to-$1.2B Manufacturing Restructuring
Load more
Scroll Up
We use cookies to give you a better experience on genengnews.com. By continuing to use our site, you are agreeing to the use of cookies as set in our
privacy policy.
Got it!
Edit with Live CSS
/* The alert message box */ .alert { padding: 20px; background-color: #ff9800; /* Red */ color: white; margin-bottom: 15px; } /* The close button */ .closebtn { margin-left: 15px; color: white; font-weight: bold; float: right; font-size: 22px; line-height: 20px; cursor: pointer; transition: 0.3s; } /* When moving the mouse over the close button */ .closebtn:hover { color: black; } .td_module_flex_2 .entry-title { font-size: 17px; line-height: 20px; }
